Amylyx Pharmaceuticals, Inc. (AMLX)

13.99 -0.39 (-2.71%) USD  |  NASDAQ  |  Mar 13, 16:00
14.19 +0.20 (+1.43%) Pre-Market: 08:03
More

Amylyx Pharmaceuticals Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Disc Medicine, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MediciNova, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade